Dana Investment Advisors, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1427514 BROOKFIELD, WI

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$4,813,105

-$1,674,753 QoQ

Shares Held

7,719

-8.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#396

of 1,329 holders

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 89% Shared 0% None 11%

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. REGN ranks #3 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	57,520	$18,181,496
2	AXSM	Axsome Therapeutics, Inc.	22,850	$5,592,994
3	REGN	Regeneron Pharmaceuticals, Inc. This page	7,719	$4,813,105
4	TGTX	Tg Therapeutics, Inc.	42,012	$2,308,139
5	VKTX	Viking Therapeutics, Inc.	57,854	$2,256,884
6	MDGL	Madrigal Pharmaceuticals, Inc.	3,677	$1,974,365
7	ZYME	Zymeworks Inc.	71,660	$1,873,192
8	IONS	Ionis Pharmaceuticals Inc	23,272	$1,845,236

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,813,105	7,719	-8.1%	Shares	Sole	2026-08-13
2026-03-31	$6,487,858	8,397	+0.0%	Shares	Sole	2026-05-14
2025-12-31	$6,479,848	8,395	+58.0%	Shares	Sole	2026-02-05
2025-09-30	$2,987,340	5,313	+8.5%	Shares	Sole	2025-11-10
2020-12-31	$2,366,272	4,898	-40.2%	Shares	Sole	2021-02-11
2020-09-30	$4,581,799	8,185	-49.2%	Shares	Sole	2020-11-10
2020-06-30	$10,058,227	16,128	-47.1%	Shares	Sole	2020-08-11
2020-03-31	$14,900,169	30,515	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.